Early detection of cytomegalovirus-specific cytotoxic T lymphocytes against cytomegalovirus antigenemia in human leukocyte antigen haploidentical hematopoietic stem cell transplantation

Kato, Ruri; Tamaki, Hiroya; Ikegame, Kazuhiro; Yoshihara, Satoshi; Kaida, Katsuji; Taniguchi, Kyoko; Inoue, Takayuki; Ishii, Shinichi; Nakata, Jun; Fujioka, Tatsuya; Eguchi, Ryoji; Soma, Toshihiro; Okada, Masaya; Ogawa, Hiroyasu
October 2015
Annals of Hematology;Oct2015, Vol. 94 Issue 10, p1707
Academic Journal
Human leukocyte antigen (HLA)-haploidentical stem cell transplantation (haplo-SCT) is associated with a high incidence of cytomegalovirus (CMV) infection, probably originating from the delayed reconstitution of CMV-specific T cell immunity. There have been few reports on the presence of CMV-specific cytotoxic T lymphocytes (CMV-CTLs) after haplo-SCT. We have studied CMV-specific immune reconstitution by measuring the absolute number of CMV-CTLs using a flow cytometry method with HLA-A2-restricted NLVPMVATV peptide dextramers. We examined the association between reconstitution patterns of CMV-CTLs and the duration of CMV antigenemia in 15 patients who underwent first allogeneic SCT from HLA-haploidentical-related donors with HLA-A2. In seven and eight patients, CMV antigenemia consecutively resolved for more than 4 weeks (the CMV antigenemia 'resolved' group) and intermittently persisted (the CMV antigenemia 'persistent' group) during a 100-day observation period, respectively. The group of the seven patients, in whom levels of CMV antigenemia were reduced to zero, had a significantly lower maximum level of CMV antigenemia than the CMV antigenemia persistent group. In contrast, the CMV antigenemia persistent group had a significantly higher maximum level of CMV-CTLs, but the levels took longer to peak. Despite no difference in general lymphocyte recovery between the two groups, the CMV antigenemia resolved group had significantly higher median CMV-CTL counts than the CMV antigenemia persistent group at 6 weeks after onset of CMV infection. Flow cytometry analysis of CMV-CTLs is a convenient method of monitoring reconstitution of CMV-specific lymphocyte immunity following haplo-SCT.


Related Articles

  • Signature profiles of CMV-specific T-cells in patients with CMV reactivation after hematopoietic SCT. Król, L.; Stuchlý, J.; Hubáček, P.; Keslová, P.; Sedláček, P.; Starý, J.; Hrušák, O.; Kalina, T. // Bone Marrow Transplantation;Aug2011, Vol. 46 Issue 8, p1089 

    Depletion of cellular immunity as a consequence of conditioning before allogeneic hematopoietic SCT (HSCT) frequently results in CMV reactivation, which may in turn lead to life-threatening infections and require timely antiviral treatment. We have investigated the functional signatures of...

  • Preface of the Special Issue: "Recent CMV Research". Dufrene, Kayla; DeBiasi, Roberta L.; Colberg-Poley, Anamaris M. // Viruses (1999-4915);Jan2014, Vol. 6 Issue 1, p336 

    A preface to the issue is presented where a congenital cytomegalovirus infection patient discusses her struggles with the disease throughout her life and her willingness to learn more about its symptoms, diagnosis, and treatment.

  • Reduced Mortality of Cytomegalovirus Pneumonia After Hematopoietic Cell Transplantation Due to Antiviral Therapy and Changes in Transplantation Practices. Erard, Veronique; Guthrie, Katherine A.; Sachiko Seo; Smith, Jeremy; MeeiLi Huang; Jason Chien; Flowers, Mary E. D.; Corey, Lawrence; Boeckh, Michael // Clinical Infectious Diseases;7/1/2015, Vol. 61 Issue 1, p31 

    Background. Despite major advances in the prevention of cytomegalovirus (CMV) disease, the treatment of CMV pneumonia in recipients of hematopoietic cell transplant remains a significant challenge. Methods. We examined recipient, donor, transplant, viral, and treatment factors associated with...

  • Foscarnet.  // Reactions Weekly;May2014, Vol. 1500 Issue 1, p19 

    An abstract of the article "UL54 foscarnet mutation in an hematopoietic stem cell transplant recipient with cytomegalovirus disease," by K. Gregg and colleagues is presented.

  • Ganciclovir.  // Reactions Weekly;Jun2015, Vol. 1554 Issue 1, p94 

    An abstract of the article "Characterization of multiple cytomegalovirus drug resistance mutations detected in a hematopoietic stem cell transplant recipient by recombinant phenotyping," by E. Drouot is presented.

  • Intrathecal Administration of High-Titer Cytomegalovirus Immunoglobulin for Cytomegalovirus Meningitis. Shin-ichiro Fujiwara; Kazuo Muroi; Raine Tatara; Ken Ohmine; Tomohiro Matsuyama; Masaki Mori; Tadashi Nagai; Keiya Ozawa // Case Reports in Hematology;2014, p1 

    Cytomegalovirus (CMV) central nervous system disease after hematopoietic stem cell transplantation (HSCT) is a rare but life-threatening complication. Here, we report a patient who developed CMV meningitis after HSCT and was treated with the combination therapy of intrathecal high-titer CMV...

  • Clostridium Cadaveris Splenic Abscess in an Adolescent. Yan, Jennifer; Hinds, Rupert; Burgner, David // Journal of Paediatrics & Child Health;Apr2018, Vol. 54 Issue 4, p460 

    No abstract available.

  • Congenital Cytomegalovirus Infection Presenting with Isolated Secretory Diarrhoea Mimicking a Congenital Diarrhoeal Disorder. Osatakul, Seksit; Chanpong, Atchariya; Pruekprasert, Pornpimol // Journal of Paediatrics & Child Health;Apr2018, Vol. 54 Issue 4, p460 

    No abstract available.

  • Lower costs associated with hematopoietic cell transplantation using reduced intensity vs high-dose regimens for hematological malignancy. Saito, A. M.; Zahrieh, D.; Cutler, C.; Ho, V. T.; Antin, J. H.; Soiffer, R. J.; Alyea, E. P.; Lee, S. J. // Bone Marrow Transplantation;Aug2007, Vol. 40 Issue 3, p209 

    We compared inpatient and outpatient costs alongside clinical outcomes associated with hematopoietic cell transplantation between 2000 and 2003 with high-dose regimens (HDCT, n=185) and with reduced intensity regimens (RICT, n=90) from human leukocyte antigen (HLA)-matched donors for patients...


Read the Article


Sorry, but this item is not currently available from your library.

Try another library?
Sign out of this library

Other Topics